Inhibition by aurintricarboxylic acid of von Willebrand factor binding to platelet GPIb, platelet retention, and thrombus formation in vivo

This publication has 20 references indexed in Scilit:

• Experimental Model of Carotid Artery Thrombosis in Rats and the Thrombolytic Activity of YM866, a Novel Modified Tissue-Type Plasminogen Activator
  The Japanese Journal of Pharmacology, 1993
• The role of von Willebrand factor and fibrinogen in platelet aggregation under varying shear stress.
  Journal of Clinical Investigation, 1991
• Isolation and chemical characterization of two structurally and functionally distinct forms of botrocetin, the platelet coagglutinin isolated from the venom of Bothrops jararaca
  Biochemistry, 1991
• Aurintricarboxylic acid in a canine model of coronary artery thrombosis.
  Circulation, 1990
• Effects of monoclonal antibodies against the platelet glycoprotein IIb/IIIa complex on thrombosis and hemostasis in the baboon.
  Journal of Clinical Investigation, 1988
• Heparin requirement in tissue-type plasminogen activator-induced experimental coronary thrombolysis. Comparison with urokinase-induced coronary thrombolysis.
  Japanese Circulation Journal, 1987
• Identical binding site on human platelets for von Willebrand factor and bovine platelet aggregating factor
  Thrombosis Research, 1980
• Human blood platelet adhesion to artery subendothelium is mediated by factor VIII–Von Willebrand factor bound to the subendothelium
  Nature, 1979
• Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1,3,4,6-tetrachloro-3a,6a-diphenylglycoluril
  Biochemical and Biophysical Research Communications, 1978
• A Specific and Reasonably Accurate Method for Routine Determination of Plasma Triglyceride
  Scandinavian Journal of Clinical and Laboratory Investigation, 1960